53

Concord Drugs LtdBOM 538965 Stock Report

Last reporting period 31 Mar, 2024

Updated 20 Sep, 2024

Last price

Market cap $B

0.002

Micro

Exchange

XBOM - Bombay Stock Exchange

View Section: Eyestock Rating

Concord Fair Value

53

The fair market value of 538965.BO stock is 15.64 INR. Relative to the market price of 36.13 INR Concord is overvalued by 56.7%

Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.

Fair Relative Value

Greatly overvalued 56.7%
15.64 INR
538965.BO Fair Value
36.13 INR
Market price of 538965.BO

Concord Valuation

Current 538965.BO share ticker price is 36.13 INR.

The fair value level of 15.64 INR can be considered as an effective entry point for long-term investors to start investing in 538965.BO stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.

Price chart is not available

1y
3y
5y
All time
Market price

Current market price

Fair value

Current price is 57% higher its fair value

Min value

Current price is 88% higher its minimum value

Max value

Current price is 26% higher its maximum value

21.09.2024

Market price:

* Eyestock is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on eyestock.io represent a recommendation to buy or sell a security.

538965.BO stock is greatly overvalued

It means the current price may concern as a High Risk Entry Point

Concord Drugs Ltd Stock Valuation Calculator

How do we value a stock?

As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.

1

Maximum P/E over 5 years

48.55

2

Median P/E over 5 years

28.32

3

Minimum P/E over 5 years

7.74

4

Earning per share (last 12 months)

0.55 INR

Maximum value

1

x

4

=

26.82 INR

Fair value

2

x

4

=

15.64 INR

Minimum value

3

x

4

=

4.27 INR

Concord Drugs Ltd price metrics

13.9

Annual return (geometric mean)

54.4

Risk (standard deviation) of returns

β

0.5

Beta (volatility compared to market)

It means that 538965.BO stock is less volatile than the broader market

Discover Undervalued Companies


View Section: Profitability